Skip to content
Esta página está disponible en españolCambiar →

Lesaka Technologies (LSAK): which funds own it

Financials →(by SIC code, unreviewed)Data as of Jun 30, 2026 (Q2 2026) · updated on Nov 6, 2026

A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.

Sections with a free account

No concentrated manager holds it. 1 officer or director bought in 6 months.

Who owns Lesaka Technologies?

Holders reporting more than 5% of the shares to the SEC (Schedules 13D/13G): Morgan Stanley, 6.6% (13G/A filed Feb 4, 2025) and Goldman Sachs Group, 6.3% (13G/A filed Feb 6, 2025). International Finance Corp is listed on Form 4 filings as an owner of more than 10%. As of Jun 30, 2026, the largest holders reported on Form 13F were Morgan Stanley (6.0% of the shares), Goldman Sachs Group (5.9%) and Rathbones Group (4.3%).

Which institutions hold the most Lesaka Technologies shares?

Per Form 13F filings as of Jun 30, 2026, as a share of all shares outstanding:

  1. 1. Morgan Stanley: 6.0%
  2. 2. Goldman Sachs Group: 5.9%
  3. 3. Rathbones Group: 4.3%
  4. 4. Hosking Partners LLP: 3.2%
  5. 5. Potomac Capital Management: 1.8%
  6. 6. Kingsway Capital Partners: 1.1%
  7. 7. Deutsche Bank Ag\: 0.5%
  8. 8. Citadel Advisors: 0.5%
  9. 9. Barclays: 0.3%
  10. 10. Intrepid Family Office: 0.3%

How much of Lesaka Technologies do institutions own?

The 43 institutions that file 13F reported 25.3% of the shares as of Jun 30, 2026.

Sources:13G/A by Morgan Stanley (Feb 4, 2025) ↗13G/A by Goldman Sachs Group (Feb 6, 2025) ↗All of the company's proxy statements on EDGAR ↗

13F percentages divide the shares each institution reports by the shares outstanding on the cover of the company's latest report before the quarter end (May 4, 2026). Entities of the same group file separately and are not added up. We hold 13D and 13G filings made since Dec 23, 2024: a holder above 5% that has not filed since then does not appear here.

Lesaka Technologies revenue

Lesaka Technologies reported annual revenue of $721.6 million for fiscal year 2026 (year ended June 30, 2026), according to its Form 10-K filed with the SEC (XBRL data).

Concentrated managers
—
All 13F: 43
Consensus
—
No score: it needs 5 or more concentrated managers
Price at Jun 30, 2026 (per 13F)
$4.97
-2.4% in the quarter · reported value ÷ shares, not the quote · See current quote ↗

Quarter flow (concentrated managers)

Concentrated managers holding it

None in the latest quarter.

Largest holders of LSAK (all 13F filers)

  • Morgan Stanley5.1 MBank or trading desk · 5.93% of the company+5,515
  • Goldman Sachs Group5.1 MBank or trading desk · 5.84% of the company−24 K
  • Rathbones Group3.7 MWealth adviser · 4.23% of the company+13 K
  • Hosking Partners LLP2.7 MType not verified · 3.15% of the company−49 K
  • Potomac Capital Management1.5 MType not verified · 1.75% of the company+403 K
  • Kingsway Capital Partners920 KSingle-position portfolio · 1.06% of the companyno data
  • Deutsche Bank Ag\439 KBank or trading desk · 0.51% of the company+340 K
  • Citadel Advisors400 KQuant or multi-manager · 0.46% of the company+327 K
  • Barclays250 KBank or trading desk · 0.29% of the company−18 K
  • Intrepid Family Office250 KType not verified · 0.29% of the company0

The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.

Held by institutions (13F)

Institutions (13F): 25.3% of the shares · top 10: 23.7% · in index firms: 0.7% of the institutional total

Share of the stock held by 13F filers

Q2 2026: 25.3%

26.8%19.9%
Q3 2021Q2 2026

Shares reported by the 43 13F filers as of Jun 30, 2026, divided by the shares outstanding on the cover of the company's latest report (May 4, 2026). It is not all institutional ownership: only managers above $100M file a 13F, and it excludes short positions. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. We only publish it where the figure is credible: not for ADRs, companies with more than one share class or stale shares-outstanding data.

Fundamentals

12-month figures to Sep 30, 2026.

Profitability
Operating margin
1.6%
Net margin
0.4%
ROE
1.5%
Growth
Revenue (TTM)
$735M
Revenue growth
8.4%
Net income (TTM)
$3.2M
Balance sheet
Quality vs sector
—

Bank, insurer or other financial company: we do not show net debt / EBITDA or free cash flow. Its cash flow moves with loans and the investment portfolio, and its debt is part of the business: those figures do not read as they do for an industrial company.

This company's sector comes from its SIC code, unreviewed, or has too few comparable companies: we do not compare it with its sector.

Figures from the statements the company filed with the SEC (10-K, 10-Q). Free cash flow = operating cash flow − capital expenditures; empty if the company does not report capex. “Quality vs sector”: 0 to 100, the average of its percentiles in ROE, operating margin, free-cash-flow margin, revenue and earnings growth and net debt / EBITDA (at least 3 needed) against companies in its sector above $300M. How each figure is calculated

Shares outstanding: buybacks and dilution

Diluted shares by fiscal year (split-adjusted)

2026: 79.7 M

79.7 M0
20172026

There is a jump that may be an undetected split: we do not show the changes.

Buybacks (FY 2026)
$339K
Share issuance
no data
Stock-based compensation
$7.0M1.0% of revenue
Dividends paid
no data

From the statements the company filed with the SEC (10-K). The change compares average diluted shares of each fiscal year, on today's basis: negative = it bought back more than it issued; positive = dilution. “No data” = the company does not report that item under a tag we can read; it does not mean zero.

Earnings quality and debt

Operating cash flow ÷ net income (12 months)
11.36

Bank or insurer: debt ratios do not apply.

From the figures the company filed with the SEC. Cash flow over net income near or above 1 means earnings are collected in cash; far below, that part is accounting. Coverage says how many times operating income pays the latest fiscal year's interest. Maturities come from the debt note of the latest annual report, counted from its closing date. “No data” never means zero.

Insiders (Form 4)

Officers and directors who bought (6 m)
1
Amount (6 m)
$184K
CEO/CFO bought (12 m)
Yes

10% owners who bought (6 m): 0

Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.

Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →

Above 5% (13D/13G)

Disclosed stakes, with their amendments. A filing is not always a purchase: there are also reductions and changes of filing entity.

This list may be incomplete: we hold 13D and 13G filings made since Dec 23, 2024. A holder above 5% that has not filed anything since then is not shown here.

  • IFC Financial Institutions Growth Fund, LP ("FIG")3.85%(fell below 5%)13D · amendmentfiling ↗Event: Sep 28, 2026 · filed: Sep 29, 2026
  • Apis Growth 132.1%(fell below 5%)13G · amendmentfiling ↗Event: Mar 2, 2026 · filed: Jul 31, 2026
  • IFC Financial Institutions Growth Fund, LP ("FIG")3.85%(fell below 5%)13D · amendmentfiling ↗Event: Jun 15, 2026 · filed: Jun 17, 2026

Above 5% over time (13D/13G)

Each holder with its filings in order. History since December 2024.

Flagged material events (8-K)

  • Sep 29, 2026Routinefiling ↗

    Change in directors or officers (Item 5.02)

  • Sep 14, 2026Routinefiling ↗

    Change in directors or officers (Item 5.02)

  • Aug 3, 2026Routinefiling ↗

    Change in directors or officers (Item 5.02)

  • Jul 30, 2026Routinefiling ↗

    Change in directors or officers (Item 5.02)

  • May 18, 2026Routinefiling ↗

    Change in directors or officers (Item 5.02)

  • Feb 27, 2026Routinefiling ↗

    Change in directors or officers (Item 5.02)

Alert items the company itself flagged in its 8-K filings with the SEC, most serious first. It is the form's label, with no interpretation from us: Item 5.02 covers routine appointments as well as a chief executive's departure; open the filing. The quoted headline is the original press release's.

All material events (8-K)

Earnings, agreements, financing, management changes and announcements from the last year, with a filter by type and a link to each filing.

Other Financials stocks in managers' portfolios

Same sector and a similar number of concentrated managers holding them. It is a list to keep exploring, not a recommendation.

All of Financials →

Follow LSAK for free

If someone reports a 5%+ stake, we email you (if you turn it on). And when you come back, see whether concentrated managers got in or out. No credit card.

Follow LSAK